ASCENIV

immune globulin intravenouS · ADMA Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASCENIV, covering 2022-09-16 to 2022-09-16. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD) [Phase 4]

See pricing